These results may provide a rationale for novel therapy approaches, as combined inhibition of Pin1 and Notch3 could suppress aggressive phenotypes, representing a useful tool to interfere with the mechanisms governing T-ALL cell extravasation into lymphoid and non-lymphoyd tissues, finally leading to the inhibition of migration and invasion processes. The gene discussed is NOTCH3; the disease is acute lymphoblastic leukemia.